TechAltis Labs raises $25 million Series A
OrbiMed and Qiming Venture Partners USA led the round, The SaaS News reports. The funding is intended to scale Altis Labs’ AI-driven clinical trial endpoint technology.
TLDR
The SaaS News reports that Altis Labs raised $25 million in Series A funding led by OrbiMed and Qiming Venture Partners USA to scale its AI-driven clinical trial endpoint technology.
Combined views
25
1 Source, first seen 10h ago
Altis Labs raises $25 million Series A
OrbiMed and Qiming Venture Partners USA led the round, The SaaS News reports. The funding is intended to scale Altis Labs’ AI-driven clinical trial endpoint technology.
TLDR
The SaaS News reports that Altis Labs raised $25 million in Series A funding led by OrbiMed and Qiming Venture Partners USA to scale its AI-driven clinical trial endpoint technology.